Codexis (CDXS) Prices 4.2857M Share Common Offering at $17.50/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
- S&P 500, Nasdaq retreat from record highs as yields and oil climb
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Chip stock could soar nearly 200%, analyst says: "If you don’t buy it, they will"
- Musk rules out TSMC role in Terafab operations; Intel gains
- HubSpot to cut 7% of workforce in restructuring plan
- Caribou Biosciences to halt CAR-T programs, explore sale
- Emera and Canadian Utilities agree to merge in $72B all-share deal
- Sportradar to sell Synergy Sports coaching unit for $170M
- Rezolve AI (RZLV) Reiterated at Overweight by Cantor Fitzgerald on Positioning as Key Component in E-Commerce Stack
After-Hours Movers 12/02: (WDR) (OMER) (CRWD) Higher; (SPLK) (VERI) (GLNG) Lower (more...)
December 2, 2020 5:29 PM ESTAfter-Hours Stock Movers:
Waddell & Reed Financial, Inc. (NYSE: WDR) 48.9% HIGHER; announced it has entered into a merger agreement with Macquarie Asset Management, the asset management division of Macquarie Group (ASX: MQG; ADR: MQBKY), under which Macquarie would acquire all of the outstanding shares of Waddell & Reed for $25.00 per share in cash representing total consideration of $1.7 billion.
Omeros (NASDAQ: OMER) 21% HIGHER; Centers for Medicare & Medicaid Services said the company's drug Omidria qualifies as a non-opioid pain management... More
Codexis (CDXS) Announces Proposed Public Offering of Common Stock
December 2, 2020 4:25 PM ESTCodexis, Inc. (Nasdaq: CDXS), a leading protein engineering company, today announced that it has commenced an underwritten public offering of shares of its common stock. All of the shares to be sold in the offering will be offered by Codexis. In addition, Codexis intends to grant to the... More



